RGS4 and cardiac hypertrophy: Exogenous overexpression of RGS4 in cardiomyocytes attenuates endothelin receptor signaling, reducing phospholipase C (PLC)-β activation, contractility in the long term, and cardiac hypertrophy [16,17,18].